Tech Company Financing Transactions
Bounce Imaging Funding Round
R42, Good Growth Capital and In-Q-Tel invested in a $4.2 million Series A capital raise for Bounce Imaging. The round was announced on 5/2/2022.
Transaction Overview
Company Name
Announced On
5/2/2022
Transaction Type
Venture Equity
Amount
$4,200,000
Round
Series A
Investors
R42 (Lead Investor)
private investors (Jack Greco)
Proceeds Purpose
The money will help Bounce Imaging scale from making hundreds of cameras a month to thousands. Last year, the startup scored a deal with U.S. Customs and Border Protection worth up to $15 million.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
203 Crescent St Building 17 102B
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Overview
Dianthus Therapeutics is advancing next generation complement therapeutics to deliver transformative medicines for patients with rare diseases. Our mission is to develop best-in-class, potent and selective antibodies of validated and emerging complement targets to transform the lives of people living with autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arino Garcia
Chief Medical Officer
Simrat Randhawa
Chief Operating Officer
Evan Thompson
Vice President
Robert Mcgarr
VP - Human Resources
Kristina Maximenko
VP - Operations
Rivka Gluck
Browse more venture capital transactions:
Prev: 5/2/2022: Hello Heart venture capital transaction
Next: 5/2/2022: Zepto venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs